Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 711 (USA) (Dr. Jansen)
· consented 2013-01-27
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate ASTHENIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-05 (study day 10.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild HYPERTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-07-23 (study day -188.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate HYPERTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-07-23 (study day -188.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.